Gnrh agonist

Gnrh agonist has been studied in 2 papers since 2024: none in people yet, 1 in animals, 1 review; 1 in the past year. The research so far is in animals. The newest paper, Sep 30, 2026: “Bone Health in Transgender Individuals: A Narrative Review on the Impact of Gender-Affirming Hormone Therapy”.

Intervention

2 papers study it1 findingUpdated

See all 2 papers on gnrh agonist

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Animals1

What did studies of gnrh agonist find?

1

Studies of gnrh agonist measured one outcome, cortisol.

Cortisol

downin mice1

1 study
  1. Gnrh agonist decreases cortisol in mice (ovariectomy-induced elevation of cortisol).

    “the administration of GnRHa suppressed the increase in FSH levels and the elevation of cortisol”

    Animalsovariectomy-induced elevation of cortisolfemales

    Activation of Follicle-Stimulating Hormone Receptor in Adrenal Zona Fasciculata Cells Promotes Cortisol Secretion: Implications for the Development of Menopause-Associated Diseases

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

More on Cortisol

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 01 paper in 12 months